Search Results - "Molina, André Sapata"

Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis by Sandri, Silvana, Hebeda, Cristina Bichels, Broering, Milena Fronza, de Paula Silva, Marina, Moredo, Luciana Facure, de Barros E Silva, Milton José, Sapata Molina, André, Lopes Pinto, Clóvis Antônio, Duprat Neto, João Pedreira, Reutelingsperger, Chris P, Gil, Cristiane Damas, Farsky, Sandra Helena Poliselli

“…Annexin A1 (AnxA1) is highly secreted by neutrophils and binds to formyl peptide receptors (FPRs) to trigger anti-inflammatory effects and efferocytosis. AnxA1…”
Get full text

Popliteal sentinel lymph node involvement in melanoma patients by Bertolli, Eduardo, Bevilacqua, José Luiz Barbosa, Molina, André Sapata, de Macedo, Mariana Petaccia, Pinto, Clovis Antonio Lopes, Duprat Neto, João Pedreira

“…Background Sentinel lymph nodes (SLN) in popliteal basins are rare, and there is controversy in literature regarding their origin, management, and outcomes…”
Get full text

Metastatic area ratio can help predict nonsentinel node positivity in melanoma patients by Bertolli, Eduardo, Macedo, Mariana Petaccia de, Pinto, Clovis Antonio Lopes, Damascena, Aline Santos, Molina, André Sapata, Duprat Neto, João Pedreira

“…Several studies suggest that melanoma patients with a positive sentinel node biopsy (SNB) can avoid having complete nodal dissection on the basis of…”
Get full text

Evaluation of Melanoma Features and Their Relationship with Nodal Disease: The Importance of the Pathological Report by Bertolli, Eduardo, de Macedo, Mariana Petaccia, Pinto, Clóvis Antonio Lopes, Damascena, Aline Santos, Molina, André Sapata, Ueno, Patricía Sayuri, Neto, João Pedreira Duprat

“…Background The pathological features of melanoma biopsies can provide significant prognostic information that can help the surgeon evaluate the risk of nodal…”
Get full text

Local therapy in advanced melanoma after immune checkpoint inhibitors aiming to achieve complete response by de Barros e Silva, Milton, Teixeira, Marcos, Lobo, Matheus, Molina, André, Bertolli, Eduardo, Santos Filho, Ivan, Castro Ribeiro, Heber, Pelizon, Antônio, Lopes Pinto, Clóvis, Duprat Neto, João

“…Background and Objectives: New scenarios for local therapy have arisen after starting immune checkpoint inhibitors (ICIs) to treat advanced melanoma (AM). The…”
Get full text

Isolated limb perfusion with hyperthermia and chemotherapy: predictive factors for regional toxicity by Neto, João Pedreira Duprat, Oliveira, Fernanda, Bertolli, Eduardo, Molina, Andre Sapata, Nishinari, Kenji, Facure, Luciana, Fregnani, Jose Humberto

“…Isolated limb perfusion combined with melphalan is an accepted treatment for obtaining locoregional control in advanced melanoma of the extremities and other…”
Get full text

Dermatofibrosarcoma protuberans of the vulva: margins assessment and reconstructive options - a report of two cases by Bertolli, Eduardo, Bretchbuhl, Eduard Renè, Camarço, William Ricardo, Campagnari, Mariane, Molina, André Sapata, Baiocchi, Glauco, Macedo, Mariana Petaccia, Pinto, Clovis Antonio, Cunha, Isabela Werneck, Neto, João Pedreira

“…Dermatofibrosarcoma Protuberans (DFSP) of the vulva is rare and oncologic surgery with free margins may lead to severe functional damage, requiring…”
Get full text

Brazilian Society of Surgical Oncology recommendations on Merkel cell carcinoma surgical treatment by Lobo, Matheus de Melo, Wainstein, Alberto Julius Alves, Barros, Aldo Vieira, Oliveira, Alexandre Ferreira, Jafelicci, Andrea Schiavinato, Molina, Andre Sapata, Bertolli, Eduardo, Riccardi, Felice, Cavarsan, Flavio, Belfort, Francisco Aparecido, Teixeira, Frederico Jose Ribeiro, DeBiasi, Gustavo Galvan, Ribeiro, Heber Salvador de Castro, Almeida, Herbert Ives Barretto, de Oliveira, Jadivan Leite, Duprat Neto, Joao Pedreira, Rebolho, Juliano Camargo, Nunes, Luiz Fernando, Junior, Manoel Jesus Pinheiro Coelho, Brandao, Miguel Angelo, Brandao, Paulo Henrique Domingues Miranda, de Souza, Rafael Oliveira, Vazquez, Vinicius de Lima, Pinheiro, Rodrigo Nascimento

“…Merkel cell carcinoma (MCC) is a rare neuroendocrine skin cancer with poor 5-year survival rates. Surgery and radiation are the current first-line treatments…”
Get full text